Day: July 1, 2025

Brings More Than Twenty Years of Biopharmaceutical Leadership Experience ANN ARBOR, Mich., July 01, 2025 (GLOBE NEWSWIRE) — Esperion (NASDAQ: ESPR) today announced it has appointed Craig Thompson, Chief Executive Officer of Cerevance, to its Board of Directors. Mr. Thompson will serve as an independent director. With Mr. Thompson’s appointment, Esperion’s Board of Directors now comprises eight members. “We are thrilled to welcome Craig to our Board of Directors. With more than two decades of biopharmaceutical industry leadership and a proven track record advancing innovative therapies, Craig brings a wealth of strategic insight and operational expertise that will be invaluable as we continue to expand our impact in cardiovascular and cardiometabolic drug development. His deep understanding of pharmaceutical commercialization and...

Well-established executive with over 20 years of experience building and leading commercial teams across diverse therapeutic markets and geographies Career focused on driving business growth and developing an integrated commercial strategy to deliver results ISELIN, N.J., July 01, 2025 (GLOBE NEWSWIRE) — Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced the appointment of Bob Jahr as Chief Executive Officer (CEO). Mr. Jahr has also been appointed to the Outlook Therapeutics Board of Directors. Lawrence A. Kenyon, who has served as Outlook Therapeutics’ Chief Financial Officer (CFO) and interim CEO, will continue serving as CFO and as a member of the Board of Directors. “We are very pleased to welcome...

Targeting 75 EH/s by Year-End211 Blocks Won in June, 25% Decrease M/MIncreased BTC Holdings* to 49,940 BTC Miami, FL, July 01, 2025 (GLOBE NEWSWIRE) — MARA Holdings, Inc. (NASDAQ: MARA) (“MARA” or the “Company”), a leading digital energy and infrastructure company, today published unaudited bitcoin (“bitcoin” or “BTC”) production updates for June 2025 and provided its hashrate outlook for the full year. Management Commentary“With 1.7 gigawatts (“GW”) of captive capacity – including 1.1 GW currently operational – and a growth pipeline exceeding 3 GW of low-cost power opportunities, we are targeting 75 exahash by the end of 2025. This target represents over 40% growth from 2024, supported by machine orders already in place,” said Fred Thiel, MARA’s chairman and CEO. “As the largest...

Highest volume of listings and capital raise in the first half of the year since 2021 Maintained leadership in switches – crossed $3 trillion in market value transferred since 2005 Driving smart policy reforms to improve regulatory processes for public companies NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Nasdaq (Nasdaq: NDAQ) announced today that in the first half of 2025, it welcomed 142 listings (IPOs), raising a total of $19.2 billion. A total of 83 operating companies and 59 SPACs listed on Nasdaq during the first six months of 2025, representing an 86% win-rate of Nasdaq-eligible listings in the U.S. market, and extending Nasdaq’s leadership to 46 consecutive quarters. In addition to the IPOs, 11 companies transferred their corporate listings to Nasdaq, crossing the threshold of $3 trillion in total market value from...

NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — SLR Investment Corp. (the “Company”) (NASDAQ: SLRC) today announced that it will release its financial results for the quarter ended June 30, 2025 on Tuesday, August 5, 2025 after the close of the financial markets. The Company will host an earnings conference call and audio webcast at 10:00 a.m. (Eastern Time) on Wednesday, August 6, 2025. All interested parties may participate in the conference call by dialing (800) 245-3047 approximately 5-10 minutes prior to the call, international callers should dial (203) 518-9765. Participants should reference SLR Investment Corp. and Conference ID: SLRC2Q25. A telephone replay will be available until August 20, 2025 and can be accessed by dialing (800) 839-8389. International callers should dial (402) 271-9156. This conference call will also be...

Tilray Brands Announces Independence Day Parties Across the U.S. NEW YORK, July 01, 2025 (GLOBE NEWSWIRE) — Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company, is excited to share that its craft beer taprooms across the U.S. are rolling out a stellar lineup of events to make this 4th of July unforgettable. From live music and limited-release brews to barbecues and Independence Day festivities, each taproom is set to bring its own unique flair to the holiday.10 Barrel Brewing10 Barrel, East Bend, OR – Over the top 4th of July food, cocktail and crowler specials. Best-dressed patriotic contest and fireworks in the parking lot. All activations are free and open to all ages. 10 Barrel, West Bend, OR-The week of festivities starts on the 2nd with a parking lot dock...

SYDNEY, July 01, 2025 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) today announced the appointment of Anthony Lewis as Chief Capital Officer, a newly established role responsible for overseeing the Company’s capital markets activity. Mr. Lewis will lead the development of IREN’s capital structure and financing strategy as the Company evaluates a range of AI infrastructure investments and associated funding requirements. Mr. Lewis brings more than two decades of experience in financial markets, including 22 years at Macquarie Group, a global financial services and asset management firm with a market capitalization of more than $50 billion and operations in 31 markets, where he most recently served as Co-Treasurer, responsible for global funding, liquidity and capital management. “Anthony’s experience across funding, capital management,...

PURCHASE, N.Y., July 01, 2025 (GLOBE NEWSWIRE) — Cognition Therapeutics, Inc., (the Company or Cognition) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, announced that the Phase 2 ‘START’ Study surpasses 50% enrollment. The START Study is being conducted with partners at the Alzheimer’s Clinical Trials Consortium (ACTC), with $81 million in grant support from the National Institute of Aging (NIA) at the National Institutes of Health. Christopher van Dyck, MD, stated, “This is an important milestone for the study and is a testament to the commitment of the investigators and site teams and a high level of interest from participants in an oral treatment with a novel approach to addressing amyloid in early Alzheimer’s disease.” Dr. Van Dyck is the director of the Yale Alzheimer’s Disease...